Alginate is named as an intervention in 3 current clinical trials in our Belgium and Taiwan registers. None are recruiting at the moment. The most common phase is Phase 4. The sponsor with the most trials is University of Mons (1). The most-studied condition is Laryngopharyngeal Reflux Disease.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Comparative Effectiveness of Alginate, Magaldrate, Sucralfate, Proton Pump Inhibitors, and Diet in Laryngopharyngeal Reflux Disease
NCT07611162 · ClinicalTrials.gov ↗ · Laryngopharyngeal Reflux Disease
|
Phase 4 | Not yet open | University of Mons | Belgium |
|
Prevention of Oral Mucositis and Improvement of Quality of Life for Patients With Breast Cancer Undergoing Adjuvant Radiotherapy
NCT06958445 · ClinicalTrials.gov ↗ · Breast Carcinoma
|
Phase 2 | By invitation | Taipei City Hospital | Taiwan |
|
Primary carE PPi dEprescRibing Trial
NCT05629143 · ClinicalTrials.gov ↗ · Heartburn, Dyspepsia, Reflux
|
Phase 4 | Active, closed | Universitaire Ziekenhuizen KU Leuven | Belgium |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| University of Mons | 1 |
| Universitaire Ziekenhuizen KU Leuven | 1 |
| Taipei City Hospital | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Belgium | 2 | 0 |
| Clinical trials in Taiwan | 1 | 0 |
A trial with sites in more than one country appears in each of those registers.
3 current trials in our Belgium and Taiwan registers name Alginate as a drug or biological intervention, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Not at the moment. None of the 3 trials in our registers is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.
University of Mons (1), Universitaire Ziekenhuizen KU Leuven (1) and Taipei City Hospital (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Alginate works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Alginate works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Alginate (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 26 Sep 2026.